RPS6 and metastatic neoplasm: Multivariate Cox analysis identified p-rpS6 as a significant prognostic factor in the whole patient group (Table 3, cancer-specific survival: 1.4 [1-1.9], p = 0.03) and patients with metastatic disease (Suppl.